These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20213080)

  • 21. Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.
    Al-Khaykanee AM; Abdel-Rahman AA; Essa A; Gadallah AA; Ali BH; Al-Aqar AA; Badr EAE; Shehab-Eldeen S
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101636. PubMed ID: 33740609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
    Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
    Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
    Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
    Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women.
    Sun MY; Du HY; Zhu AN; Liang HY; de Garibay GR; Li FX; Li M; Yang XX
    Int J Mol Sci; 2015 Feb; 16(2):4121-35. PubMed ID: 25689428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of NR5A2 and RYR2 3'UTR polymorphisms on the risk of breast cancer in a Chinese Han population.
    Wei Y; Wang X; Zhang Z; Zhao C; Chang Y; Bian Z; Zhao X
    Breast Cancer Res Treat; 2020 Aug; 183(1):1-8. PubMed ID: 32572717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic susceptibility loci for breast cancer by estrogen receptor status.
    Garcia-Closas M; Chanock S
    Clin Cancer Res; 2008 Dec; 14(24):8000-9. PubMed ID: 19088016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province.
    Xu F; Li D; Zhang Q; Fu Z; Yuan W; Pang D; Li D
    Breast Cancer Res Treat; 2012 Jun; 133(3):1105-13. PubMed ID: 22399187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
    Wang Y; Yang SH; Hsu PW; Chien SY; Wang CQ; Su CM; Dong XF; Zhao YM; Tang CH
    Medicine (Baltimore); 2019 Nov; 98(44):e17854. PubMed ID: 31689877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin pathway genes and breast cancer risk among Chinese women.
    Deming SL; Lu W; Beeghly-Fadiel A; Zheng Y; Cai Q; Long J; Shu XO; Gao YT; Zheng W
    Breast Cancer Res Treat; 2012 Apr; 132(2):693-9. PubMed ID: 22138747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population.
    Sueta A; Ito H; Kawase T; Hirose K; Hosono S; Yatabe Y; Tajima K; Tanaka H; Iwata H; Iwase H; Matsuo K
    Breast Cancer Res Treat; 2012 Apr; 132(2):711-21. PubMed ID: 22160591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
    Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
    J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic association of deleted in colorectal carcinoma variants with breast cancer risk: A case-control study.
    Liu X; Wang X; Fu SW; Wang M; Kang H; Guan H; Zhang S; Ma X; Lin S; Liu K; Feng Y; Dai C; Dai Z
    Oncotarget; 2016 May; 7(22):32765-73. PubMed ID: 27127179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population.
    Zhou F; Qiu LX; Cheng L; Wang MY; Li J; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Wei QY
    Oncotarget; 2016 Dec; 7(50):82384-82395. PubMed ID: 27577072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
    Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
    Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
    Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
    Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province.
    Fu Z; Li D; Jiang W; Wang L; Zhang J; Xu F; Pang D; Li D
    Breast Cancer Res Treat; 2010 Feb; 120(1):195-202. PubMed ID: 19585237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
    Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
    Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single nucleotide polymorphism of the TNRC9 gene associated with breast cancer risk in Chinese Han women.
    Chen F; Zhou J; Xue Y; Yang S; Xiong M; Li Y; Liu Q
    Genet Mol Res; 2014 Jan; 13(1):182-7. PubMed ID: 24446301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
    Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.